Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Keldsen

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
The Pharmacogenomics Journal|April 7, 2010
Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancerT K Bergmann, C Brasch-Andersen, H Gréen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2013
Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancerM K Boisen, J S Johansen, C Dehlendorff, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
The Pharmacogenomics Journal|April 7, 2010
Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancerT K Bergmann, C Brasch-Andersen, H Gréen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2013
Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancerM K Boisen, J S Johansen, C Dehlendorff, et al.
Pageof 3